Sector consensus Telix Pharmaceuticals Limited
Equities
TLX
AU000000TLX2
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.64 AUD | +7.33% |
|
+13.05% | +30.71% |
| 04-10 | Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Amid Lingering Geopolitical Uncertainty, CPI Focus | MT |
| 04-10 | Top Premarket Gainers | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| 23.21 | +58.51% | 12 | |||||||
| 675.78 | +31.22% | 23 | |||||||
| 408.2 | +31.82% | 26 | |||||||
| 257,416.67 | +28.9% | 24 | |||||||
| 232.25 | +38.79% | 20 | |||||||
| 133.7 | +38.65% | 20 | |||||||
| 250.86 | +22.65% | 16 | |||||||
| 500.08 | +1.33% | 12 | |||||||
| 71.85 | +11.99% | 14 | |||||||
| 97.6 | +29.84% | 23 | |||||||
| 121.82 | +12.9% | 7 | |||||||
| 629.24 | +99.04% | 17 | |||||||
| 73.64 | +32.58% | 11 | |||||||
| 197.64 | +12.52% | 14 | |||||||
| 55.46 | +35.64% | 14 | |||||||
| 131.92 | +23.51% | 13 | |||||||
| 75.43 | +75.66% | 14 | |||||||
| 37.34 | +20.03% | 12 | |||||||
| 119.14 | +40.09% | 21 | |||||||
| Average | 13,750.1 | +33.98% | 16 | ||||||
| Weighted average by Cap. | 26,438.99 | +31.70% | 19 |
- Stock Market
- Equities
- TLX Stock
- Sector Telix Pharmaceuticals Limited
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















